Felicita Baratelli

2.3k total citations
20 papers, 1.7k citations indexed

About

Felicita Baratelli is a scholar working on Immunology, Oncology and Pharmacology. According to data from OpenAlex, Felicita Baratelli has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Felicita Baratelli's work include Immunotherapy and Immune Responses (7 papers), Inflammatory mediators and NSAID effects (7 papers) and T-cell and B-cell Immunology (5 papers). Felicita Baratelli is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Inflammatory mediators and NSAID effects (7 papers) and T-cell and B-cell Immunology (5 papers). Felicita Baratelli collaborates with scholars based in United States, Switzerland and South Korea. Felicita Baratelli's co-authors include Steven M. Dubinett, Sherven Sharma, Karen L. Reckamp, Seok-Chul Yang, Mariam Dohadwala, Raj K. Batra, Ying Lin, Li Zhu, Nathalie Heuzé‐Vourc'h and Min Huang and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Felicita Baratelli

20 papers receiving 1.7k citations

Peers

Felicita Baratelli
C. Christian Johansson Sweden
Elias Gounaris United States
N East United Kingdom
David G. Alleva United States
Sofia Edin Sweden
Norma Llansa United States
Wen‐Jye Lin Taiwan
Jeffrey Subleski United States
Mark A. Guthridge Australia
Tomohisa Baba Japan
C. Christian Johansson Sweden
Felicita Baratelli
Citations per year, relative to Felicita Baratelli Felicita Baratelli (= 1×) peers C. Christian Johansson

Countries citing papers authored by Felicita Baratelli

Since Specialization
Citations

This map shows the geographic impact of Felicita Baratelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felicita Baratelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felicita Baratelli more than expected).

Fields of papers citing papers by Felicita Baratelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felicita Baratelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felicita Baratelli. The network helps show where Felicita Baratelli may publish in the future.

Co-authorship network of co-authors of Felicita Baratelli

This figure shows the co-authorship network connecting the top 25 collaborators of Felicita Baratelli. A scholar is included among the top collaborators of Felicita Baratelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felicita Baratelli. Felicita Baratelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Christina, Felicita Baratelli, Guang‐Qian Xiao, Michael N. Koss, & Wafaa Elatre. (2018). Evaluation of Cyclin D1 as a Discriminatory Immunohistochemical Biomarker for Idiopathic Pulmonary Fibrosis. Applied immunohistochemistry & molecular morphology. 27(2). e11–e15. 4 indexed citations
2.
Baratelli, Felicita, et al.. (2014). Do mast cells play a pathogenetic role in neurofibromatosis type 1 and ulcerative colitis?. Experimental and Molecular Pathology. 96(2). 230–234. 18 indexed citations
3.
Garon, Edward B., Felicita Baratelli, G. Wang, et al.. (2014). Phase I Trial of Trans-thoracic Injection of CCL21 Gene Modified Dendritic Cells in Human Non-small Cell Lung Carcinoma. Journal of Surgical Research. 186(2). 558–558. 3 indexed citations
4.
Kachroo, Puja, Ling Zhang, Felicita Baratelli, et al.. (2013). IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 32(1). 97–97. 66 indexed citations
5.
Sharma, Sherven, Li Zhu, Minu K. Srivastava, et al.. (2013). CCL21 Chemokine Therapy for Lung Cancer.. PubMed. 1(1). 10–15. 12 indexed citations
6.
Kar, Upendra K., Minu K. Srivastava, Åsa Andersson, et al.. (2011). Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth. PLoS ONE. 6(5). e18758–e18758. 89 indexed citations
7.
Garon, Edward B., Felicita Baratelli, Dörthe Schaue, et al.. (2010). Phase I trial of CCL21 gene modified dendritic cells in non-small cell lung cancer.. Journal of Clinical Oncology. 28(15_suppl). TPS157–TPS157. 2 indexed citations
8.
Baratelli, Felicita, Jay M. Lee, Saswati Hazra, et al.. (2010). PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.. PubMed. 2(4). 356–67. 59 indexed citations
9.
Baratelli, Felicita, Hidetoshi Takedatsu, Saswati Hazra, et al.. (2008). Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer. Journal of Translational Medicine. 6(1). 38–38. 39 indexed citations
10.
Peebles, Katherine A., Jay M. Lee, Jenny T. Mao, et al.. (2007). Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Review of Anticancer Therapy. 7(10). 1405–1421. 60 indexed citations
11.
Baratelli, Felicita, Ying Lin, Li Zhu, et al.. (2005). Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells. The Journal of Immunology. 175(3). 1483–1490. 464 indexed citations
12.
Heuzé‐Vourc'h, Nathalie, Harnisha Dalwadi, Felicita Baratelli, et al.. (2005). IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression. Biochemical and Biophysical Research Communications. 333(2). 470–475. 35 indexed citations
13.
Sharma, Sherven, Seok-Chul Yang, Li Zhu, et al.. (2005). Tumor Cyclooxygenase-2/Prostaglandin E2–Dependent Promotion of FOXP3 Expression and CD4+CD25+ T Regulatory Cell Activities in Lung Cancer. Cancer Research. 65(12). 5211–5220. 413 indexed citations
14.
Baratelli, Felicita, Kostyantyn Krysan, Nathalie Heuzé‐Vourc'h, et al.. (2005). PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells. Journal of Leukocyte Biology. 78(2). 555–564. 39 indexed citations
15.
Baratelli, Felicita, Nathalie Heuzé‐Vourc'h, Kostyantyn Krysan, et al.. (2004). Prostaglandin E2-Dependent Enhancement of Tissue Inhibitors of Metalloproteinases-1 Production Limits Dendritic Cell Migration through Extracellular Matrix. The Journal of Immunology. 173(9). 5458–5466. 49 indexed citations
16.
Mao, Jenny T., Steven M. Dubinett, Bradley J. Adams, et al.. (2004). Modulation of Pulmonary Leukotriene B4 Production by Cyclooxygenase-2 Inhibitors and Lipopolysaccharide. Clinical Cancer Research. 10(20). 6872–6878. 41 indexed citations
17.
Mao, Jenny T., Michael D. Roth, Kenneth J. Serio, et al.. (2003). Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.. PubMed. 9(16 Pt 1). 5835–41. 38 indexed citations
18.
Riedl, Karen, Felicita Baratelli, Raj K. Batra, et al.. (2003). Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells.. Molecular Cancer. 2(1). 35–35. 30 indexed citations
19.
Mao, Jenny T., Donald P. Tashkin, Paula Belloni, et al.. (2003). All- trans Retinoic Acid Modulates the Balance of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients With Emphysema *. CHEST Journal. 124(5). 1724–1732. 56 indexed citations
20.
Sharma, Sherven, Marina Stolina, Felicita Baratelli, et al.. (2003). Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.. PubMed. 9(3). 961–8. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Christian Johansson Breakdown of academic impact, for papers by Elias Gounaris Breakdown of academic impact, for papers by N East Breakdown of academic impact, for papers by David G. Alleva Breakdown of academic impact, for papers by Sofia Edin Breakdown of academic impact, for papers by Norma Llansa Breakdown of academic impact, for papers by Wen‐Jye Lin Breakdown of academic impact, for papers by Jeffrey Subleski Breakdown of academic impact, for papers by Mark A. Guthridge Breakdown of academic impact, for papers by Tomohisa Baba
Rankless by CCL
2026